Demo
Close Language Tab
Locate us
Languages
C
Caplin Point Laboratories Ltd Pharmaceuticals
₹ 2,030.50 +9.50 (0.47%)
  • NSE
  • BSE

Overview

  • BSE Code 524742
  • NSE Symbol CAPLIPOINT
  • ISIN Demat INE475E01026
  • Book Value (₹) 223.77
  • Face Value (₹) 2.00
  • Market Cap (₹ Cr.) 15,212.98
  • P/E (TTM) 43.12
  • EPS (TTM) 46.42
  • Div Yield (%) 0.30

Performance

Today’s Low 2,012.10
Today’s High 2,036.00

2,030.50
52W Low 1,599.00
52W High 2,641.00

2,030.50
Open 2,019.00
Prev. Close 2,021.00
Volume 19,380.00

Corporate Actions

Caplin Point Laboratories Limited - Disclosure under SEBI Takeover Regulations
Sep 29, 2025

Caplin Point Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Caplin Point Laboratories Limited - Trading Window
Sep 29, 2025

Caplin Point Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Caplin Point Laboratories Limited - Press Release
Apr 23, 2025

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated April 23, 2025, titled "Press Release regarding receipt of USFDA Approval".

About Caplin Point Laboratories Ltd

Incorporated in Apr.'90, Caplin Point Laboratories was promoted by P C Partheeban, T Palanisamy, S Karunakaran, S Jayaraman and B A Ahmed. The company manufactures pharmaceutical formulations in the form of tablets, ointments and capsules, liquid orals and oral powders. _x000D_ _x000D_ The company came out with a public issue in Nov.'94 and expanded its production capacity by setting up a new unit to manufacture its range of products, at Pondicherry. The company has retained its SSI status even after the expansion and thus will be out of the purview of the DPCO. During 1993-94, Triwin (a partnership firm) was merged with Caplin Point. _x000D_ _x000D_ The company entered into a technical agreement with American Remedies, US, and Concord Laboratories, US, for specific products, with a 30% buyback arrangement. It also imports bio-technological products to market them in India._x000D_ _x000D_ The company has established a trading branch in Nairobi, Kenya, to sell its products in East Africa. It has also established a warehouse in Miami, US, by entering into a marketing tie-up with Lockett Medical Corporation, US._x000D_
Founded: 1990
Chairman: C C Paarthipan
Managing Director: Sridhar Ganesan
Address: Ashvich Towers 3rd Floor, No 3 Developed Plots Ind Estat, Chennai, Tamil Nadu, 600096,
HO Tel: 91-044-28156653/6901/28156905

Frequently Asked Questions

What is the price of Caplin Point Laboratories Ltd share today? +
How to buy stock of Caplin Point Laboratories Ltd? +
What is the 52 Week High and Low of Caplin Point Laboratories Ltd? +
What is the PE ratio of Caplin Point Laboratories Ltd? +
What is the Market Cap of Caplin Point Laboratories Ltd? +